CARsgen (02171) Reports Share Repurchase Activity and Treasury Share Update

Bulletin Express

Nov 20, 2025

On 20 November 2025, CARsgen Therapeutics Holdings Limited (stock code: 02171) repurchased 168,000 of its ordinary shares on the Hong Kong Stock Exchange. The repurchase price ranged between HKD 17.54 and HKD 17.85, for a total amount of approximately HKD 2.97 million.

Following this transaction, the number of issued shares (excluding treasury shares) was adjusted from 574,974,905 to 574,806,905, while treasury shares increased from 2,967,500 to 3,135,500. The shares repurchased on 21 October 2025 and 23 October 2025, totaling 455,000, remain pending for cancellation.

According to the authorization granted on 22 May 2025, a total of 3,590,500 shares have been repurchased so far, representing 0.624% of the company’s total shares in issue as of that resolution date. Currently, the company is subject to a share-issuance moratorium period running until 20 December 2025, in compliance with relevant listing rules and regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1113062695"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1113062695\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1113062695?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-20 21:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1113062695","market":"hk","top_or_hot":-1,"title":"CARsgen (02171) Reports Share Repurchase Activity and Treasury Share Update","media":"Bulletin Express","content":"<p>On 20 November 2025, CARsgen Therapeutics Holdings Limited (stock code: 02171) repurchased 168,000 of its ordinary shares on the Hong Kong Stock Exchange. The repurchase price ranged between HKD 17.54 and HKD 17.85, for a total amount of approximately HKD 2.97 million.</p>\n<p>Following this transaction, the number of issued shares (excluding treasury shares) was adjusted from 574,974,905 to 574,806,905, while treasury shares increased from 2,967,500 to 3,135,500. The shares repurchased on 21 October 2025 and 23 October 2025, totaling 455,000, remain pending for cancellation.</p>\n<p>According to the authorization granted on 22 May 2025, a total of 3,590,500 shares have been repurchased so far, representing 0.624% of the company’s total shares in issue as of that resolution date. Currently, the company is subject to a share-issuance moratorium period running until 20 December 2025, in compliance with relevant listing rules and regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CARsgen (02171) Reports Share Repurchase Activity and Treasury Share Update</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCARsgen (02171) Reports Share Repurchase Activity and Treasury Share Update\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-20 21:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On 20 November 2025, CARsgen Therapeutics Holdings Limited (stock code: 02171) repurchased 168,000 of its ordinary shares on the Hong Kong Stock Exchange. The repurchase price ranged between HKD 17.54 and HKD 17.85, for a total amount of approximately HKD 2.97 million.</p>\n<p>Following this transaction, the number of issued shares (excluding treasury shares) was adjusted from 574,974,905 to 574,806,905, while treasury shares increased from 2,967,500 to 3,135,500. The shares repurchased on 21 October 2025 and 23 October 2025, totaling 455,000, remain pending for cancellation.</p>\n<p>According to the authorization granted on 22 May 2025, a total of 3,590,500 shares have been repurchased so far, representing 0.624% of the company’s total shares in issue as of that resolution date. Currently, the company is subject to a share-issuance moratorium period running until 20 December 2025, in compliance with relevant listing rules and regulatory requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02171","symbol_name":"科济药业-B","start_time":0,"source_url":"","article_id":"1113062695","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1113062695","pubTimestamp":1763643735,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"On 20 November 2025, CARsgen Therapeutics Holdings Limited (stock code: 02171) repurchased 168,000 of its ordinary shares on the Hong Kong Stock Exchange. The repurchase price ranged between HKD...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02171":"科济药业-B"},"translate_title":"科济安(02171)报告股票回购活动和库存股更新","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02171":1},"content_text":"On 20 November 2025, CARsgen Therapeutics Holdings Limited (stock code: 02171) repurchased 168,000 of its ordinary shares on the Hong Kong Stock Exchange. The repurchase price ranged between HKD 17.54 and HKD 17.85, for a total amount of approximately HKD 2.97 million.\nFollowing this transaction, the number of issued shares (excluding treasury shares) was adjusted from 574,974,905 to 574,806,905, while treasury shares increased from 2,967,500 to 3,135,500. The shares repurchased on 21 October 2025 and 23 October 2025, totaling 455,000, remain pending for cancellation.\nAccording to the authorization granted on 22 May 2025, a total of 3,590,500 shares have been repurchased so far, representing 0.624% of the company’s total shares in issue as of that resolution date. Currently, the company is subject to a share-issuance moratorium period running until 20 December 2025, in compliance with relevant listing rules and regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}